Account
ET Medialabs bags performance marketing mandate for Drip Capital
Mumbai: ET Medialabs, the growth marketing and analytics company has announced its latest collaboration with Drip capital, a California-and India-based fintech company focused on solving the working capital problem for SME exporters using technology.
ET MediaLabs will help Drip Capital generate more leads through this association by providing focused, functional performance marketing services to achieve sustainable growth for the brand, said the statement.
“We are thrilled to have partnered with Drip Capital in helping them ramp up their customer base through performance marketing campaigns with an aim to drive lead generation, especially SQL (Sales Qualified Leads),” said ET MediaLabs CEO Raghav Kansal. “Both the companies will work together in order to scale the brand to newer heights. Our partnership with Drip Capital will help us further our mission of helping companies achieve their goal of sustainable growth.”
Drip Capital uses technology to rebuild core parts of the international trade finance infrastructure and make the underwriting and financing of international B2B transactions seamless for small businesses.
“The entire ecosystem is now turning towards growth marketing to generate more leads. We are thrilled to associate with ET Medialabs for our performance marketing requirements,” stated Drip Capital co-founder and CEO Pushkar Mukewar. “The company works with high-end businesses and offers excellent performance marketing services to its clients. I believe this association would help us reach our TG efficiently.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
